BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1379 related articles for article (PubMed ID: 17437432)

  • 21. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
    BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of retroperitoneal lymph node dissection after induction chemotherapy for metastatic non-seminomatous germ cell tumors.
    Muramaki M; Hara I; Miyake H; Yamada Y; Okada H; Kamidono S
    Int J Urol; 2004 Sep; 11(9):763-7. PubMed ID: 15379941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
    Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
    Steiner H; Peschel R; Bartsch G
    BJU Int; 2008 Aug; 102(3):310-4. PubMed ID: 18325053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
    Carver BS; Serio AM; Bajorin D; Motzer RJ; Stasi J; Bosl GJ; Vickers AJ; Sheinfeld J
    J Clin Oncol; 2007 Dec; 25(35):5603-8. PubMed ID: 17998544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
    Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
    Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
    Svatek RS; Spiess PE; Sundi D; Tu SM; Tannir NM; Brown GA; Kamat AM; Wood CG; Pisters LL
    Cancer; 2009 Mar; 115(6):1310-7. PubMed ID: 19156903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.
    Heidenreich A; Ohlmann C; Hegele A; Beyer J
    Eur Urol; 2005 Jan; 47(1):64-71. PubMed ID: 15582251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
    Stephenson AJ; Sheinfeld J
    Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
    Carver BS; Bianco FJ; Shayegan B; Vickers A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Urol; 2006 Jul; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H; Peschel R; Janetschek G; Höltl L; Berger AP; Bartsch G; Hobisch A
    Urology; 2004 Mar; 63(3):550-5. PubMed ID: 15028456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
    Heidenreich A; Thüer D; Polyakov S
    Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.